Simplex Trading’s Bicycle Therapeutics BCYC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$23.2K Sell
6,300
-39,000
-86% -$158K ﹤0.01% 6907
2026
Q2
$192K Buy
45,300
+15,700
+53% +$72K ﹤0.01% 4766
2026
Q1
$137K Buy
29,600
+28,800
+3,600% +$165K ﹤0.01% 4727
2025
Q4
$5.66K Sell
800
-9,500
-92% -$70K ﹤0.01% 7362
2025
Q3
$79K Buy
10,300
+8,800
+587% +$66.4K ﹤0.01% 6008
2025
Q2
$10K Sell
1,500
-800
-35% -$6.37K ﹤0.01% 7294
2025
Q1
$19K Hold
2,300
– – ﹤0.01% 6605
2024
Q4
$32K Sell
2,300
-3,000
-57% -$64.3K ﹤0.01% 6280
2024
Q3
$119K Sell
5,300
-100
-2% -$2.31K ﹤0.01% 5053
2024
Q2
$109K Buy
5,400
+2,100
+64% +$47.4K ﹤0.01% 5288
2024
Q1
$82K Sell
3,300
-9,700
-75% -$206K ﹤0.01% 5783
2023
Q4
$235K Buy
13,000
+8,500
+189% +$141K ﹤0.01% 4506
2023
Q3
$90K Buy
4,500
+3,200
+246% +$73.2K ﹤0.01% 5192
2023
Q2
$33K Sell
1,300
-96,500
-99% -$2.24M ﹤0.01% 6247
2023
Q1
$2.08M Buy
97,800
+96,500
+7,423% +$2.42M ﹤0.01% 1922
2022
Q4
$38K Buy
1,300
+1,200
+1,200% +$32.2K ﹤0.01% 6192
2022
Q3
$2K Sell
100
-2,800
-97% -$66.6K ﹤0.01% 9230
2022
Q2
$48K Sell
2,900
-22,900
-89% -$483K ﹤0.01% 6537
2022
Q1
$1.13M Buy
25,800
+24,300
+1,620% +$1.13M ﹤0.01% 2762
2021
Q4
$91K Buy
+1,500
New +$82.8K ﹤0.01% 6404

Other funds holding BCYC

Simplex Trading's BCYC Position: Q3 2026 in Review

Simplex Trading increased its Bicycle Therapeutics (BCYC) stake by 33% in Q3 2026, buying an estimated $47.3K and bringing the position to 46,923 shares worth $173K. The position accounts for ﹤0.01% of the portfolio, ranked #4792.

Simplex Trading first reported a position in BCYC in Q4 2021 and has held it in 14 quarters since. The position peaked at $1.7M in Q2 2023. 25 funds tracked by Wall St. Rank hold BCYC as of Q3 2026.

  • Simplex Trading held 46,923 shares of Bicycle Therapeutics worth $173K as of Q3 2026.
  • Simplex Trading bought 11,691 Bicycle Therapeutics shares in Q3 2026, an estimated $47.3K.
  • Bicycle Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #4792 holding.
  • Simplex Trading first reported a position in Bicycle Therapeutics in Q4 2021 and has held it in 14 quarters since.
  • Simplex Trading's Bicycle Therapeutics position peaked at $1.7M in Q2 2023.
  • 25 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q3 2026.

Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.